Concepedia

Mehmet S Copur

MS

Statistics

Publications

3

Citations

578

H-Index

3

Active since

2011

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Mehmet S Copur is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, cancer pharmacology, and breast oncology.

Publications per year

2011–2022

3

Publications

3

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

, , +17

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Nicholas J. Robert, Mansoor N. Saleh, Devchand Paul et al. · Clinical Breast Cancer · 2011 · 118 citations · Full text

, , +8

Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center

Mehmet S Copur, C. T. GNEWUCH, Megan Schriner et al. · Journal of Oncology Pharmacy Practice · 2017 · 13 citations

, , +13

1–3 of 3